Please assess the completion status of the following clinical trial:

Trial Title: EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Females, 18-75 years of age inclusive.~* American Society of Anesthesiologist (ASA) physical status 1-3.~* Undergoing open total abdominal hysterectomy (i.e., laparoscopic procedures are not sufficient) without any concurrent surgical procedure(s).~* Physically and mentally able to participate in the study and complete all study assessments.~* Able to give fully informed consent to participate in this study after demonstrating a good understanding of the risks and benefits of the TAP.~Exclusion Criteria:~* Demonstrated hypersensitivity or idiosyncratic reactions to amide-type local anesthetics.~* Any subject whose anatomy, or surgical procedure, in the opinion of the Investigator, might preclude the potential successful performance of a TAP.~* Any subject who in the opinion of the Investigator might be harmed or be a poor candidate for participation in the study.~* Any subject, who in the opinion of the Investigator, is on chronic pain medicine.~* Subjects who have received any investigational drug within 30 days prior to study drug administration, or planned administration of another investigational product or procedure during their participation in this study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- EXPAREL Group 1 (Type: EXPERIMENTAL): EXPAREL 266 mg diluted with saline to a volume of 40 mL
- EXPAREL Group 2 (Type: EXPERIMENTAL): EXPAREL 266 mg diluted with saline to a volume of 60 mL

Based on this trial design, predict the completion outcome and termination type (if applicable).